Literature DB >> 10711253

Mononuclear leucocyte function tests in the assessment of the biocompatibility of peritoneal dialysis fluids.

H F Brulez1, P M ter Wee, S V Snijders, A J Donker, H A Verbrugh.   

Abstract

BACKGROUND: Previous studies showed that the currently used dextrose based peritoneal dialysis fluids impair several leucocyte functions. AIMS: To determine which in vitro mononuclear leucocyte (monocyte) function tests most clearly reflect the biocompatibility of peritoneal dialysis fluid.
METHODS: Monocytes were tested for phagocytic capacity, bactericidal activity, Fc and C3 receptor expression, and chemiluminescence response, and by analysis of the release of interleukin 8 (IL-8) and tumour necrosis factor alpha (TNF alpha) in the presence of test fluids. Cytokine release was studied in an alternative dynamic in vitro peritoneal dialysis model in which monocytes were exposed to test fluid that was continuously equilibrated with an interstitial fluid-like medium through a microporous membrane. The chemiluminescence response by stressed monocytes was also tested after an 18 h recovery period. All tests were performed during or after exposure to different degrees of glycerol induced osmotic stress and after exposure to a 1% milk-whey derived, polypeptide enriched test fluid. Cells incubated in 0.1% gel Hanks buffer (GH) served as control.
RESULTS: Osmotic stress induced impairment of leucocyte function was found by the chemiluminescence assay (mean (SEM): 179 (20)% v 138 (23)% after 30 minutes in 0.5% and 1.5% glycerol, respectively) and by the analysis of IL-8 released by monocytes (44 (9) ng in 0.7% glycerol v 40 (7) ng in 2.0% glycerol). Only the chemiluminescence assay showed a protective effect of polypeptides on leucocyte function (after > or = 60 minutes). If monocytes were allowed to recover in culture medium after exposure to test fluids, the changes in chemiluminescence response appeared to be reversible after a 30 minute exposure, but became more pronounced after 60 and 120 minutes. The phagocytosis and bacterial killing assays were less sensitive. The observations carried out with the phagocytosis assay did not correspond with the Fc or C3 receptor density data.
CONCLUSIONS: The release of IL-8 by peripheral blood monocytes in a two compartment model and their chemiluminescence response are appropriate assays for the assessment of changes in leucocyte function in response to different peritoneal dialysis fluids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10711253      PMCID: PMC501657          DOI: 10.1136/jcp.52.12.901

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  23 in total

Review 1.  Organisms causing peritonitis.

Authors:  H A Verbrugh
Journal:  Contrib Nephrol       Date:  1990       Impact factor: 1.580

2.  In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.

Authors:  N Topley; R Mackenzie; M M Petersen; M J Beavis; D Williams; N Thomas; D Faict; F Peluso; G A Coles; M Davies
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

Review 3.  The measurement of oxygen-derived free radicals and related substances in medicine.

Authors:  G F Weber
Journal:  J Clin Chem Clin Biochem       Date:  1990-09

4.  Peritoneal dialysis solution induces apoptosis of mesothelial cells.

Authors:  A H Yang; J Y Chen; Y P Lin; T P Huang; C W Wu
Journal:  Kidney Int       Date:  1997-04       Impact factor: 10.612

5.  Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function.

Authors:  H M Alobaidi; G A Coles; M Davies; D Lloyd
Journal:  Nephrol Dial Transplant       Date:  1986       Impact factor: 5.992

6.  Peptides as substitute osmotic agents for glucose in peritoneal dialysate.

Authors:  E Klein; R A Ward; T E Williams; P W Feldhoff
Journal:  ASAIO Trans       Date:  1986 Jul-Sep

7.  Neutrophil function in hyperosmotic NaCl is preserved by phosphoenol pyruvate.

Authors:  T Matsumoto; P van der Auwera; Y Watanabe; M Tanaka; N Ogata; S Naito; J Kumazawa
Journal:  Urol Res       Date:  1991

8.  The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications.

Authors:  D L Dunn; R A Barke; D H Ahrenholz; E W Humphrey; R L Simmons
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

9.  Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration.

Authors:  T Liberek; N Topley; A Jörres; G A Coles; G M Gahl; J D Williams
Journal:  J Am Soc Nephrol       Date:  1993-02       Impact factor: 10.121

10.  Serum lipids and lipoproteins during continuous ambulatory peritoneal dialysis.

Authors:  B Lindholm; H E Norbeck
Journal:  Acta Med Scand       Date:  1986
View more
  5 in total

Review 1.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

2.  Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model.

Authors:  Ho Won Lee; Yong Hyun Jeon; Mi-Hye Hwang; Jung-Eun Kim; Tae-in Park; Jeoung-Hee Ha; Sang-Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

3.  The effects of arginine glutamate, a promising excipient for protein formulation, on cell viability: Comparisons with NaCl.

Authors:  Priscilla Kheddo; Alexander P Golovanov; Kieran T Mellody; Shahid Uddin; Christopher F van der Walle; Rebecca J Dearman
Journal:  Toxicol In Vitro       Date:  2016-02-10       Impact factor: 3.500

4.  Addition of Alanyl-Glutamine to Dialysis Fluid Restores Peritoneal Cellular Stress Responses - A First-In-Man Trial.

Authors:  Klaus Kratochwill; Michael Boehm; Rebecca Herzog; Katharina Gruber; Anton Michael Lichtenauer; Lilian Kuster; Dagmar Csaicsich; Andreas Gleiss; Seth L Alper; Christoph Aufricht; Andreas Vychytil
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

5.  Steviol glycosides as an alternative osmotic agent for peritoneal dialysis fluid.

Authors:  Valeria Kopytina; Lucía Pascual-Antón; Nora Toggweiler; Eva-María Arriero-País; Lisa Strahl; Patricia Albar-Vizcaíno; David Sucunza; Juan J Vaquero; Sonja Steppan; Dorothea Piecha; Manuel López-Cabrera; Guadalupe-Tirma González-Mateo
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.